373 related articles for article (PubMed ID: 20729465)
1. Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.
Linderholm KR; Skogh E; Olsson SK; Dahl ML; Holtze M; Engberg G; Samuelsson M; Erhardt S
Schizophr Bull; 2012 May; 38(3):426-32. PubMed ID: 20729465
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.
Schwieler L; Larsson MK; Skogh E; Kegel ME; Orhan F; Abdelmoaty S; Finn A; Bhat M; Samuelsson M; Lundberg K; Dahl ML; Sellgren C; Schuppe-Koistinen I; Svensson C; Erhardt S; Engberg G
J Psychiatry Neurosci; 2015 Mar; 40(2):126-33. PubMed ID: 25455350
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
Sekine A; Kuroki Y; Urata T; Mori N; Fukuwatari T
Neurochem Res; 2016 Sep; 41(9):2256-66. PubMed ID: 27161376
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia.
Nilsson LK; Linderholm KR; Engberg G; Paulson L; Blennow K; Lindström LH; Nordin C; Karanti A; Persson P; Erhardt S
Schizophr Res; 2005 Dec; 80(2-3):315-22. PubMed ID: 16125901
[TBL] [Abstract][Full Text] [Related]
5. Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.
Plitman E; Iwata Y; Caravaggio F; Nakajima S; Chung JK; Gerretsen P; Kim J; Takeuchi H; Chakravarty MM; Remington G; Graff-Guerrero A
Schizophr Bull; 2017 Jul; 43(4):764-777. PubMed ID: 28187219
[TBL] [Abstract][Full Text] [Related]
6. Increased Levels of Kynurenic Acid in the Cerebrospinal Fluid in Patients with Hydrocephalus.
Kepplinger B; Baran H; Kronsteiner C; Reuss J
Neurosignals; 2019; 27(1):1-11. PubMed ID: 31059212
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis.
Cao B; Chen Y; Ren Z; Pan Z; McIntyre RS; Wang D
Neurosci Biobehav Rev; 2021 Apr; 123():203-214. PubMed ID: 33513412
[TBL] [Abstract][Full Text] [Related]
8. Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice.
Wang XD; Notarangelo FM; Wang JZ; Schwarcz R
Brain Res; 2012 May; 1455():1-9. PubMed ID: 22498176
[TBL] [Abstract][Full Text] [Related]
9. Decreased Plasma Levels of Kynurenine and Kynurenic Acid in Previously Treated and First-Episode Antipsychotic-Naive Schizophrenia Patients.
Marković M; Petronijević N; Stašević M; Stašević Karličić I; Velimirović M; Stojković T; Ristić S; Stojković M; Milić N; Nikolić T
Cells; 2023 Dec; 12(24):. PubMed ID: 38132134
[TBL] [Abstract][Full Text] [Related]
10. Age-related increase of kynurenic acid in human cerebrospinal fluid - IgG and beta2-microglobulin changes.
Kepplinger B; Baran H; Kainz A; Ferraz-Leite H; Newcombe J; Kalina P
Neurosignals; 2005; 14(3):126-35. PubMed ID: 16088227
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid kynurenine and kynurenic acid concentrations are associated with coma duration and long-term neurocognitive impairment in Ugandan children with cerebral malaria.
Holmberg D; Franzén-Röhl E; Idro R; Opoka RO; Bangirana P; Sellgren CM; Wickström R; Färnert A; Schwieler L; Engberg G; John CC
Malar J; 2017 Jul; 16(1):303. PubMed ID: 28754152
[TBL] [Abstract][Full Text] [Related]
12. Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia.
Szymona K; Zdzisińska B; Karakuła-Juchnowicz H; Kocki T; Kandefer-Szerszeń M; Flis M; Rosa W; Urbańska EM
Neurotox Res; 2017 Jul; 32(1):17-26. PubMed ID: 28275903
[TBL] [Abstract][Full Text] [Related]
13. Kynurenic Acid Levels are Increased in the CSF of Alzheimer's Disease Patients.
González-Sánchez M; Jiménez J; Narváez A; Antequera D; Llamas-Velasco S; Martín AH; Arjona JAM; Munain AL; Bisa AL; Marco MP; Rodríguez-Núñez M; Pérez-Martínez DA; Villarejo-Galende A; Bartolome F; Domínguez E; Carro E
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32276479
[TBL] [Abstract][Full Text] [Related]
14. Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures.
Heyes MP; Saito K; Devinsky O; Nadi NS
Epilepsia; 1994; 35(2):251-7. PubMed ID: 8156942
[TBL] [Abstract][Full Text] [Related]
15. Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controls.
Zhang Z; Zhang M; Luo Y; Ni X; Lu H; Wen Y; Fan N
Hum Psychopharmacol; 2020 Jul; 35(4):e2738. PubMed ID: 32352599
[TBL] [Abstract][Full Text] [Related]
16. Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brain.
Alkondon M; Pereira EF; Eisenberg HM; Kajii Y; Schwarcz R; Albuquerque EX
J Pharmacol Exp Ther; 2011 Jun; 337(3):572-82. PubMed ID: 21270133
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
[TBL] [Abstract][Full Text] [Related]
18. Imbalanced kynurenine pathway in schizophrenia.
Kegel ME; Bhat M; Skogh E; Samuelsson M; Lundberg K; Dahl ML; Sellgren C; Schwieler L; Engberg G; Schuppe-Koistinen I; Erhardt S
Int J Tryptophan Res; 2014; 7():15-22. PubMed ID: 25288889
[TBL] [Abstract][Full Text] [Related]
19. Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity.
Kegel ME; Johansson V; Wetterberg L; Bhat M; Schwieler L; Cannon TD; Schuppe-Koistinen I; Engberg G; Landén M; Hultman CM; Erhardt S
Psychiatry Res; 2017 Jan; 247():105-112. PubMed ID: 27886578
[TBL] [Abstract][Full Text] [Related]
20. Decreased cerebrospinal fluid kynurenic acid in epileptic spasms: A biomarker of response to corticosteroids.
Yan J; Kothur K; Innes EA; Han VX; Jones HF; Patel S; Tsang E; Webster R; Gupta S; Troedson C; Menezes MP; Antony J; Ardern-Holmes S; Tantsis E; Mohammad S; Wienholt L; Pires AS; Heng B; Guillemin GJ; Guller A; Gill D; Bandodkar S; Dale RC
EBioMedicine; 2022 Oct; 84():104280. PubMed ID: 36174397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
